Search results

Jump to navigation Jump to search
  • {{r|Clinical practice guideline}}
    590 bytes (74 words) - 17:26, 11 January 2010
  • {{r|Clinical practice guideline}}
    617 bytes (81 words) - 17:26, 11 January 2010
  • ...emia Working Group. [http://www.guideline.gov/content.aspx?id=9907 VA/DoD clinical practice guideline for the management of dyslipidemia]. Washington (DC): Department of Veteran
    2 KB (292 words) - 03:58, 6 June 2012
  • {{r|Clinical practice guideline}}
    751 bytes (96 words) - 11:59, 11 January 2010
  • {{r|Clinical practice guideline}}
    847 bytes (107 words) - 15:32, 11 January 2010
  • [[Clinical practice guideline]]s guide assessment of PAD.<ref>{{Cite journal | doi = 10.1016/j.jacc.2011. [[Clinical practice guideline]]s help manage PAD.<ref>{{Cite journal | doi = 10.1016/j.jacc.2011.08.023
    5 KB (616 words) - 07:58, 30 September 2011
  • {{r|Clinical practice guideline}}
    968 bytes (121 words) - 15:42, 11 January 2010
  • [[Clinical practice guideline]]s have address this in children<ref name="pmid15605048">{{cite journal |au
    2 KB (215 words) - 22:44, 15 January 2009
  • [[Clinical practice guideline]]s are available to guide treatment.<ref name="pmid18582201">{{cite journal
    2 KB (308 words) - 14:33, 2 February 2023
  • {{r|Clinical practice guideline}}
    2 KB (212 words) - 11:56, 11 January 2010
  • [[Clinical practice guideline]]s address diagnosis.<ref name="pmid20307191">{{cite journal| author=Cohen
    2 KB (305 words) - 07:42, 19 August 2011
  • ...search.org/cite&retmode=ref&cmd=prlinks&id=24682348 }} </ref>. European [[clinical practice guideline]]s recommend [[anticoagulant]]s if the CHA<sub>2</sub>DS<sub>2</sub>-VASc i
    5 KB (641 words) - 13:44, 10 April 2024
  • {{r|Clinical practice guideline}}
    2 KB (203 words) - 11:57, 11 January 2010
  • ...}</ref> The most recent study used by the [[systematic review]] for this [[clinical practice guideline]] was in 2008.<ref name="pmid18799557">{{cite journal |author=Johnson CD, C A joint [[clinical practice guideline]] by the American Cancer Society, the US Multi-Society Task Force on Colore
    8 KB (1,056 words) - 13:29, 10 February 2023
  • [[Clinical practice guideline]]s address the use of vena cava filters.<ref name="pmid18574272">{{cite jou ...odnick JE, Tobolic T et al.| title=Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family
    6 KB (874 words) - 15:07, 22 August 2010
  • Urethritis is diagnosed according to [[clinical practice guideline]]s if:<ref name="pmid16888612">{{cite journal |author=Workowski KA, Berman ...ted States [[Centers for Disease Control and Prevention]] have published [[clinical practice guideline]]s for treatment.<ref name="pmid16888612">{{cite journal |author=Workowski
    4 KB (567 words) - 03:03, 16 February 2010
  • Auto-populated based on [[Special:WhatLinksHere/Clinical practice guideline]]. Needs checking by a human.
    2 KB (310 words) - 12:22, 18 April 2024
  • ...ethods of evidence synthesis used by the Task Force in formulating their [[clinical practice guideline]]s have been described in detail.<ref>{{cite web |url=http://www.ahrq.gov/c
    2 KB (298 words) - 00:51, 25 June 2009
  • A [[clinical practice guideline]] by the [[U.S. Preventive Services Task Force]] concludes there is insufic
    2 KB (244 words) - 11:11, 2 September 2011
  • ...and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2008 | volume= 93 | issue= 9 | p
    4 KB (572 words) - 14:31, 4 February 2011
View ( | ) (20 | 50 | 100 | 250 | 500)